Theme Post-market Clinical Follow-up Target audience Manufacturers, Notified bodies Products concerned MD (including Legacy Devices)* Regulatory references MDR (EU) 2017/745 Article 61 Annex XIV – Part B EN – This guide provides a detailed evaluation...
Publications : All the News
MDCG 2020-7 : Post-market clinical follow-up (PMCF) Plan Template. A guide for manufacturers and notified bodies – April 2020
Theme Post-Market Clinical Follow-up Target audience Manufacturers, Notified bodies Product concerned MD (including Legacy Devices)* Regulatory references MDR (EU) 2017/745 Article 61 Annex XIV – Part B EN - This guide provides a detailed template for...
MDCG 2020-6 : Regulation (EU) 2017/745: Clinical evidence needed for medical devices previously CE marked under Directives 93/42/EEC or 90/385/EEC – April 2020
Theme Clinical Evaluation – clinical evidence Target audience Manufacturer, Notified bodies Product concerned MD CE-marked under Directives Regulatory reference MDR (EU) 2017/745 Article 61 Annex XIV – Part A Documents mentioned MEDDEV 2.7/1 rev. 4 (2016) : Clinical...
MDCG 2020-5 : Clinical Evaluation – Equivalence. A guide for manufacturers and notified bodies – April 2020
Theme Clinical Evaluation - Equivalence Target Audience Manufacturers Products concerned MD and Products of Annex XVI Regulatory references MDR (EU) 2017/745 Article 61 Annex XIV PART A (3) Documents mentioned MEDDEV 2.7/1 rev. 4 (2016) : Clinical evaluation: Guide...
MDCG 2020-4 : Guidance on temporary extraordinary measures related to medical device Notified Body audits during COVID-19 quarantine orders and travel restrictions – April 2020
Theme COVID-19 - Audit Target Audience Notified Bodies, Manufacturers, Subcontractors Products concerned MD, IVD Documents mentioned IAF MD 4 (Mandatory Document for the Use of Information and Communication Technology (ICT) for Auditing/Assessment Purposes) ...
MDCG 2020-3 Rev.1 : Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD and AIMDD – March 2020
Theme Transitional provisions – significant changes Target Audience Manufacturers, Notified Bodies Product concerned Medical Devices that are covered by a valid certificate issued in accordance with a Directive and that continues to be placed on the market after the...
MDCG 2020-2 Rev. 1 : Class I Transitional provisions under Article 120 (3 and 4) – (MDR) – March 2020
Theme Transitional provisions Target Audience Manufacturers Products Concerned Class I MD (excluding Im, Is) in accordance with the Directive 93/42/CEE that change class in accordance with the Regulation Regulatory reference MDR (EU) 2017/745 Article 120(3) et 120(4)...
MDCG 2020-1 : Guidance on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software – March 2020
Theme Clinical evaluation - Software Target Audience Manufacturers Products concerned SaMD and Software as a part of a MD Regulatory reference MDR (EU) 2017/745 Article 61 Article 2(51) IVDR (EU) 2017/746 Article 56 Article 2(36) Documents mentioned...
MDCG 2019-16 Rev.1 : Guidance on cybersecurity for medical devices – December 2019
Theme Cybersecurity Target Audience Manufacturer Products Concerned MD that include programmable electronic systems and software that are MD in their own right Regulatory reference MDR (EU) 2017/745 Annex I IVDR (EU) 2017/746 Annex I Documents mentioned - ...
MDCG 2019-15 Rev.1 : Guidance notes for manufacturers of class I medical device – December 2019
Theme Marketing Target Audience Manufacturers, Person designated in article 16(1) of the MDR Products Concerned Class I MD Regulatory reference MDR (EU) 2017/745 Article 16(1) Documents mentioned This document provides a summary of the regulatory obligations...
Select your topic
UDI System
Quality
Digital health
Regulation
Electrical devices
PMS / PMCF
Clinical evaluation
Process / Production
Risk management